Drugs / MicroRepair ABX
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07088666 | Aug 2025 → Feb 2026 | gingivitis, smooth surface dental caries | University of Pavia | Completed | No outcome recorded |
| — | NCT07088653 | Aug 2025 → Feb 2026 | gingivitis, smooth surface dental caries | University of Pavia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MicroRepair ABX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07088653 ↗ |
| Known as | MicroRepair ABX mouthwash | “MicroRepair® ABX mouthwash, which contains biomimetic zinc-hydroxyapatite microcrystals with antibacterial components, has shown promising properties in reducing plaque and...” NCT07088666 ↗ |
| Route | Oral | “The mouthwash is used twice daily (10 mL for 30 seconds) after toothbrushing” NCT07088666 ↗ |